v3.26.1
SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Total revenue, net $ 391,918 $ 382,653
Cost of goods sold 174,936 188,221
Research and development 23,501 24,728
Selling, general & administrative 178,235 181,497
Intangible asset amortization 3,776 3,704
Total costs and expenses 380,448 398,150
Operating income (loss) 11,470 (15,497)
Interest income 4,106 4,420
Interest expense (22,465) (18,815)
Other income, net 4,480 (144)
Loss before income taxes (2,409) (30,036)
Specialty Surgery    
Segment Reporting Information [Line Items]    
Total revenue, net 283,135 280,664
Tissue Reconstruction    
Segment Reporting Information [Line Items]    
Total revenue, net 108,783 101,989
Operating Segments | Specialty Surgery    
Segment Reporting Information [Line Items]    
Total revenue, net 283,135 280,664
Cost of goods sold 110,475 109,861
Research and development 11,853 14,795
Selling, general & administrative 77,681 83,787
Intangible asset amortization 0 0
Total costs and expenses 200,009 208,443
Operating income (loss) 83,126 72,221
Operating Segments | Tissue Reconstruction    
Segment Reporting Information [Line Items]    
Total revenue, net 108,783 101,989
Cost of goods sold 37,459 49,270
Research and development 7,532 5,972
Selling, general & administrative 43,526 42,304
Intangible asset amortization 0 0
Total costs and expenses 88,517 97,546
Operating income (loss) 20,266 4,443
Corporate and Other    
Segment Reporting Information [Line Items]    
Total revenue, net 0 0
Cost of goods sold 27,002 29,090
Research and development 4,116 3,961
Selling, general & administrative 57,028 55,406
Intangible asset amortization 3,776 3,704
Total costs and expenses 91,922 92,161
Operating income (loss) $ (91,922) $ (92,161)